Invention Grant
- Patent Title: Use of SAM68 for modulating signaling through the TNF receptor
- Patent Title (中): 使用SAM68通过TNF受体调节信号
-
Application No.: US13284792Application Date: 2011-10-28
-
Publication No.: US08598137B2Publication Date: 2013-12-03
- Inventor: Parameswaran Ramakrishnan , David Baltimore
- Applicant: Parameswaran Ramakrishnan , David Baltimore
- Applicant Address: US CA Pasadena
- Assignee: California Institute of Technology
- Current Assignee: California Institute of Technology
- Current Assignee Address: US CA Pasadena
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K39/395 ; C07H21/04

Abstract:
Sam68 plays a role in TNF-dependent signaling, including NF-kB signaling and extrinsic activation of apoptosis. In some embodiments, inhibitors of Sam68 are administered to inhibit TNF-dependent signaling, for example to inhibit NF-kB signaling or apoptosis in a patient in need. In some embodiments, functional Sam68 is administered to increase TNF-dependent signaling, for example to induce apoptosis in a patient in need. In some embodiments, methods are provided determining whether the TNF-dependent or TNF-independent branch of a signaling pathway is active in a cell or cells, or for drug screening applications.
Public/Granted literature
- US20120121608A1 USE OF SAM68 FOR MODULATING SIGNALING THROUGH THE TNF RECEPTOR Public/Granted day:2012-05-17
Information query
IPC分类: